Find clinical trials for Breast Cancer in Los Angeles, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Los Angeles, CA, USA:
standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...
Phase 2
Los Angeles, California, United States of America and 2 other locations
(ICI) on on 3-year Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") resectable breast...
Phase 2
Los Angeles, California, United States and 3 other locations
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...
Phase 1, Phase 2
Los Angeles, California, United States and 4 other locations
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
Duarte, California, United States and 10 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Santa Monica, California, United States and 35 other locations
This trial will evaluate the use of immunotherapy and PARP inhibition in a population with incurable advanced breast cancer associa ...
Phase 2
Los Angeles, California, United States of America
in combination with either of two chemotherapy regimens (weekly paclitaxel or capecitabine) in unresectable/metastatic triple negative breast...
Phase 1, Phase 2
Los Angeles, California, United States of America and 1 other location
A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...
Phase 1
Santa Monica, California, United States and 8 other locations
This will be a Phase 2 clinical trial to assess somatostatin receptor (SSTR) expression in Stage IV estrogen receptor positive (ER+) breast ...
Phase 2
Irvine, California, United States
A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, stage II-III, Estrogen Rec ...
Phase 2
Los Angeles, California, United States and 14 other locations
Clinical trials
Research sites
Resources
Legal